NEW YORK, April 4 (Reuters) - Watson Pharmaceuticals has recalled one lot, or about 28,000 units, of its fentanyl pain patch after ingredient levels were found to have deviated from specifications, a company spokeswoman said on Friday.
NEW YORK, April 4 (Reuters) - Watson Pharmaceuticals has recalled one lot, or about 28,000 units, of its fentanyl pain patch after ingredient levels were found to have deviated from specifications, a company spokeswoman said on Friday.
